Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
JAMA
    September 2026
  1. RUBIN R
    Caffeine and Cardiovascular Health: What the Science Says.
    JAMA. 2026 Sep 18. doi: 10.1001/jama.2026.16716.
    >> Share

  2. ANDERER S
    How Do Cardiovascular Risks Vary Across Nicotine Products?
    JAMA. 2026 Sep 18. doi: 10.1001/jama.2026.14723.
    >> Share

    August 2026

  3. LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Research Summary.
    JAMA. 2026 Aug 29:e2617421. doi: 10.1001/jama.2026.17421.
    >> Share

  4. MONTALESCOT G, Ferrari E, Souteyrand G, Bouleti C, et al
    LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.
    JAMA. 2026 Aug 29:e2617302. doi: 10.1001/jama.2026.17302.
    >> Share

  5. RAY KK, Stevens CAT
    A Marathon, Not a Sprint-AMUNDSEN and LDL-C Lowering After Myocardial Infarction.
    JAMA. 2026 Aug 29. doi: 10.1001/jama.2026.16837.
    >> Share

  6. ABBASI J
    Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement.
    JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17524.
    >> Share

  7. SELVANAYAGAM JB, Cleland JGF, Hillis GS, Pasupathy S, et al
    Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
    JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17078.
    >> Share


  8. Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: Research Summary.
    JAMA. 2026 Aug 28:e2617332. doi: 10.1001/jama.2026.17332.
    >> Share

  9. HUANG X, Petito LC, Allen NB, Blankstein R, et al
    Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations.
    JAMA. 2026 Aug 26. doi: 10.1001/jama.2026.13233.
    >> Share

    July 2026
  10. ANDERER S
    Ischemic Heart Disease Deaths Increasingly Tied to BMI, Hyperglycemia.
    JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.9497.
    >> Share

  11. RAZO C, DeCleene NK, Johnson CO, Stark BA, et al
    Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
    JAMA. 2026 Jul 29:e268628. doi: 10.1001/jama.2026.8628.
    >> Share

  12. HUANG J
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10549.
    >> Share

  13. GOOD CB, Do S, Peasah S
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10552.
    >> Share

  14. MARSTON NA, Bohula EA, Sabatine MS
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis-Reply.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10555.
    >> Share

  15. PENG AW, Zahid S, Zhang S, Bhatla A, et al
    Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline.
    JAMA. 2026 Jul 20:e2611152. doi: 10.1001/jama.2026.11152.
    >> Share

  16. YUAN J, Jiang X, Lu ZK
    Lead Exposure and the Coronary Heart Disease Epidemic.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9341.
    >> Share

  17. LANPHEAR BP
    Lead Exposure and the Coronary Heart Disease Epidemic-Reply.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9344.
    >> Share

  18. EINSTEIN AJ, Paez D
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging-Reply.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8929.
    >> Share

  19. LI S, Jiang R
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8926.
    >> Share

  20. ANDERER S
    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.
    JAMA. 2026 Jul 2. doi: 10.1001/jama.2026.9468.
    >> Share

    June 2026
  21. STEG PG
    Primary Composite Outcome Corrected in a Trial of Transfusion Strategy in Myocardial Infarction and Anemia.
    JAMA. 2026 Jun 24. doi: 10.1001/jama.2026.10006.
    >> Share

  22. BADVE SV, Perkovic V, Jha V, Ramachandran R, et al
    Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
    JAMA. 2026 Jun 4. doi: 10.1001/jama.2026.9379.
    >> Share


  23. Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: Research Summary.
    JAMA. 2026 Jun 4:e269463. doi: 10.1001/jama.2026.9463.
    >> Share

  24. BANSAL N, Winkelmayer WC
    Rivaroxaban for Cardiovascular Disease Prevention in Chronic Kidney Disease: High Risk, but No Reward?
    JAMA. 2026 Jun 4. doi: 10.1001/jama.2026.9780.
    >> Share

    May 2026
  25. MORELLI N, Marotti C, Gallerini S
    Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke.
    JAMA. 2026 May 27. doi: 10.1001/jama.2026.4816.
    >> Share

  26. MA G, Zhong L, Hao J
    Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke-Reply.
    JAMA. 2026 May 27. doi: 10.1001/jama.2026.4819.
    >> Share

  27. ANDERER S
    Cognitive Decline May Precede Cardiovascular Events by Up to 8 Years.
    JAMA. 2026 May 15. doi: 10.1001/jama.2026.6183.
    >> Share

  28. XIONG Y, Che F, Wang H, Hao M, et al
    Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial.
    JAMA. 2026 May 8. doi: 10.1001/jama.2026.4292.
    >> Share


  29. Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: Research Summary.
    JAMA. 2026 May 8:e264503. doi: 10.1001/jama.2026.4503.
    >> Share

  30. ANDERER S
    Syphilis Linked to Higher Risk of Some Cardiovascular Outcomes.
    JAMA. 2026 May 8. doi: 10.1001/jama.2026.2132.
    >> Share


  31. Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: Research Summary.
    JAMA. 2026 May 8:e265288. doi: 10.1001/jama.2026.5288.
    >> Share

  32. LIU X, Zhang F, Zhang C, Li Z, et al
    Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial.
    JAMA. 2026 May 8:e265245. doi: 10.1001/jama.2026.5245.
    >> Share

    April 2026
  33. BOND RM, Debbink MP, Geller A, Lieu TA, et al
    Preventing Pregnancy-Related Cardiovascular Disease Burden: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2026 Apr 21. doi: 10.1001/jama.2026.6717.
    >> Share

    March 2026
  34. WINCHESTER DE, Mehta JJ, Alexander JT
    Perioperative Cardiovascular Medication Management for Noncardiac Surgery.
    JAMA. 2026 Mar 31. doi: 10.1001/jama.2026.0067.
    >> Share

  35. LANPHEAR BP
    Reframing the Coronary Heart Disease Epidemic-The Role of Lead Exposure.
    JAMA. 2026 Mar 30. doi: 10.1001/jama.2026.3041.
    >> Share

  36. STANAWAY JD, Spearman S, DeCleene NK, Garcia V, et al
    Lead-Attributable Cardiovascular Disease Burden: Global Burden of Disease Study 2023.
    JAMA. 2026 Mar 30:e262197. doi: 10.1001/jama.2026.2197.
    >> Share

  37. VOHRA AS, Alexander JT, Shah AP
    Management of Acute Coronary Syndrome.
    JAMA. 2026 Mar 30. doi: 10.1001/jama.2026.1214.
    >> Share


  38. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Research Summary.
    JAMA. 2026 Mar 28:e263429. doi: 10.1001/jama.2026.3429.
    >> Share

  39. MARSTON NA, Bohula EA, Bhatia AK, De Ferrari GM, et al
    Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial.
    JAMA. 2026 Mar 28:e263277. doi: 10.1001/jama.2026.3277.
    >> Share

  40. ABBASI J
    MASALA Study Suggests Earlier Cardiovascular Vigilance Needed for People With South Asian Ancestry.
    JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1798.
    >> Share

    February 2026
  41. EINSTEIN AJ, Williams MC, Weir-McCall JR, Shaw LJ, et al
    Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
    JAMA. 2026 Feb 25:e260703. doi: 10.1001/jama.2026.0703.
    >> Share

  42. ANDERER S
    Cardiovascular Disease Risk Climbs Earlier for Men.
    JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26395.
    >> Share

  43. XU C, Qu JZ, Wang D
    Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.25368.
    >> Share

  44. HERRMANN FEM, Jeppsson A, Hagl C
    Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting -Reply.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.25371.
    >> Share

  45. MA G, Mo R, Zuo Y, Ma Q, et al
    Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical Trial.
    JAMA. 2026 Feb 5. doi: 10.1001/jama.2026.0210.
    >> Share


  46. Tenecteplase for Acute Non-Large Vessel Occlusion Ischemic Stroke: Research Summary.
    JAMA. 2026 Feb 5:e260263. doi: 10.1001/jama.2026.0263.
    >> Share

    January 2026
  47. RUBIN R
    Stress May Link Depression and Anxiety to Cardiovascular Disease.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.25865.
    >> Share

  48. BERGSTROM G, Engstrom G, Bjornson E, Adiels M, et al
    Coronary Computed Tomography Angiography in Prediction of First Coronary Events.
    JAMA. 2026;335:245-254.
    >> Share

  49. COMBES A, Saura O, Nesseler N, Lebbah S, et al
    Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.
    JAMA. 2026;335:60-69.
    >> Share

  50. PANT S
    RSV Infection Associated With Increased Cardiovascular Risks.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23005.
    >> Share

    November 2025
  51. HSU M, Shah A, Jordan A, Gold MS, et al
    Therapeutic Use of Cannabis and Cannabinoids: A Review.
    JAMA. 2025 Nov 26. doi: 10.1001/jama.2025.19433.
    >> Share

  52. PANT S
    Meta-Analysis: Viral Infections May Raise Cardiovascular Risks.
    JAMA. 2025 Nov 14. doi: 10.1001/jama.2025.19736.
    >> Share

  53. KOUGIAS P, Sharath SE, Zhan M, Carson JL, et al
    Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial.
    JAMA. 2025 Nov 8:e2520841. doi: 10.1001/jama.2025.20841.
    >> Share

  54. PANT S
    FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19724.
    >> Share

  55. PANT S
    Nighttime Light Exposure Associated With Increased Cardiovascular Risk.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19729.
    >> Share

    October 2025
  56. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    >> Share

  57. PAN Y, Miao Z, Huo X
    Intra-Arterial Tenecteplase After Successful Endovascular Therapy for Acute Stroke-Reply.
    JAMA. 2025 Oct 23. doi: 10.1001/jama.2025.16273.
    >> Share

  58. ZHAO YT
    Intra-Arterial Tenecteplase After Successful Endovascular Therapy for Acute Stroke.
    JAMA. 2025 Oct 23. doi: 10.1001/jama.2025.16270.
    >> Share

  59. PANT S
    Cardiovascular Conditions Lead Global Disease Burden Over the Past 30 Years.
    JAMA. 2025 Oct 17. doi: 10.1001/jama.2025.17515.
    >> Share

  60. HERRMANN FEM, Jeppsson A, Kirov H, Charitos EI, et al
    Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting.
    JAMA. 2025 Oct 9:e2514891. doi: 10.1001/jama.2025.14891.
    >> Share

    September 2025
  61. ZHU J, Zhang W
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12790.
    >> Share

  62. GAO M, Cao T, Wu Q
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12787.
    >> Share

  63. GARRISON SR, Kolber MR, Korownyk CS
    Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12796.
    >> Share

  64. CEDERNAES J, Benedict C
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12784.
    >> Share

  65. FENG S, Li H, Sun R
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12793.
    >> Share

  66. FREEDMAN AA, Perak AM, Ernst LM, Borders A, et al
    High Blood Pressure in Childhood and Premature Cardiovascular Disease Mortality.
    JAMA. 2025 Sep 7:e2514405. doi: 10.1001/jama.2025.14405.
    >> Share

  67. HOFMANN R, James S, Sundqvist MO, Warme J, et al
    Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial.
    JAMA. 2025 Sep 1:e2515047. doi: 10.1001/jama.2025.15047.
    >> Share

    August 2025
  68. PUSTJENS TFS, Veenstra L, Camaro C, Ruiters AW, et al
    Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial.
    JAMA. 2025 Aug 31:e2516189. doi: 10.1001/jama.2025.16189.
    >> Share

  69. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    >> Share

  70. CHU HY, Murray AF
    Shot Through the Heart-Can RSV Vaccination Reduce Risk of Cardiovascular Outcomes?
    JAMA. 2025 Aug 30. doi: 10.1001/jama.2025.16705.
    >> Share

    July 2025
  71. WU J, Kanter GP, Wagner TH, Chu D, et al
    Impact of the MISSION Act on Quality and Outcomes of Major Cardiovascular Procedures Among Veterans.
    JAMA. 2025 Jul 31. doi: 10.1001/jama.2025.11661.
    >> Share

  72. ANDERER S
    Invasive Approach Fails to Reduce Deaths in Older Adults With Acute Coronary Syndromes.
    JAMA. 2025 Jul 18. doi: 10.1001/jama.2025.10335.
    >> Share

  73. ANDERER S
    Obesity Drugs Considered First-Line Option for Cardiovascular Risk.
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.10324.
    >> Share

  74. MIAO Z, Luo G, Song L, Sun D, et al
    Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy: The ANGEL-TNK Randomized Clinical Trial.
    JAMA. 2025 Jul 5:e2510800. doi: 10.1001/jama.2025.10800.
    >> Share

  75. YADAV A, Usman MS, Gupta R
    Combining Coronary Calcium Score With Treatment in Familial Coronary Artery Disease.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.6482.
    >> Share

  76. MARWICK TH, Whitmore K, Nicholls SJ
    Combining Coronary Calcium Score With Treatment in Familial Coronary Artery Disease-Reply.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.6485.
    >> Share

    June 2025
  77. SAXENA M, Laffin L, Borghi C, Fernandez Fernandez B, et al
    Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
    JAMA. 2025 Jun 30:e259413. doi: 10.1001/jama.2025.9413.
    >> Share

    May 2025
  78. KIM JH, Rim AJ, Miller JT, Jackson M, et al
    Cardiac Arrest During Long-Distance Running Races.
    JAMA. 2025;333:1699-1707.
    >> Share

  79. LEE CJ, Ihm SH, Shin DH, Jeong JO, et al
    Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
    JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129.
    >> Share

  80. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    >> Share

    April 2025
  81. PEI YY
    Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0688.
    >> Share

  82. HO PM, Glorioso TJ, Bull S
    Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications-Reply.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0694.
    >> Share

  83. YUAN J, Zhao J, Lu K
    Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0691.
    >> Share

  84. ABRAMOWITZ SA, Levin MG, Damrauer SM
    Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores-Reply.
    JAMA. 2025 Apr 7. doi: 10.1001/jama.2025.0621.
    >> Share

  85. SHAN D
    Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores.
    JAMA. 2025 Apr 7. doi: 10.1001/jama.2025.0618.
    >> Share

  86. ANDERER S
    FDA Updates Testosterone Labeling for Blood Pressure and Cardiovascular Risks.
    JAMA. 2025 Apr 4. doi: 10.1001/jama.2025.3240.
    >> Share

    March 2025
  87. KRISHNAN V, Huang X, Perak AM, Coresh J, et al
    Discordance of 10- and 30-Year Predicted Risk for Cardiovascular Disease in US Adults.
    JAMA. 2025 Mar 31:e252868. doi: 10.1001/jama.2025.2868.
    >> Share

  88. RODGERS L
    7 Takeaways for Primary Care Clinicians From the Updated Acute Coronary Syndromes Guideline.
    JAMA. 2025 Mar 28. doi: 10.1001/jama.2025.2931.
    >> Share

  89. WU Y, Meng J, Gao S
    Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease.
    JAMA. 2025 Mar 27. doi: 10.1001/jama.2025.0031.
    >> Share

  90. NISSEN SE
    Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply.
    JAMA. 2025 Mar 27. doi: 10.1001/jama.2025.0034.
    >> Share

  91. NASIR K, Blankstein R
    Transforming the Cardiovascular Disease Prevention Paradigm: See Disease, Treat Disease.
    JAMA. 2025 Mar 5. doi: 10.1001/jama.2025.2323.
    >> Share

  92. NERLEKAR N, Vasanthakumar SA, Whitmore K, Soh CH, et al
    Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial.
    JAMA. 2025 Mar 5:e250584. doi: 10.1001/jama.2025.0584.
    >> Share

    February 2025
  93. ANDERER S
    Supine Hypertension Linked to Cardiovascular Risk Regardless of Seated Blood Pressure.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0544.
    >> Share

  94. DEMASI M, Redberg RF, Abramson JD
    Statins for Primary Prevention of Cardiovascular Disease.
    JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26588.
    >> Share

  95. LLOYD-JONES DM, Khan S
    Statins for Primary Prevention of Cardiovascular Disease-Reply.
    JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26594.
    >> Share

  96. DIAO JA, Wadhera RK, Manrai AK
    Statins for Primary Prevention of Cardiovascular Disease-Reply.
    JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26591.
    >> Share

    January 2025
  97. WILSON LM, Anderson TS
    Trends in Preventive Aspirin Use by Atherosclerotic Cardiovascular Risk.
    JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.27333.
    >> Share

  98. HUANG J, Yang J, Liu C, Li L, et al
    Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke: The POST-TNK Randomized Clinical Trial.
    JAMA. 2025 Jan 13. doi: 10.1001/jama.2024.23466.
    >> Share

    December 2024
  99. ANDERER S
    Cardiovascular Disease Deaths Climb in Rural US, Particularly Among Younger Adults.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.25507.
    >> Share

  100. HO PM, Glorioso TJ, Allen LA, Blankenhorn R, et al
    Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial.
    JAMA. 2024 Dec 2:e2421739. doi: 10.1001/jama.2024.21739.
    >> Share

    November 2024
  101. ABRAMOWITZ SA, Boulier K, Keat K, Cardone KM, et al
    Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores.
    JAMA. 2024 Nov 16:e2423784. doi: 10.1001/jama.2024.23784.
    >> Share

  102. KHAN SS, Pencina MJ
    Polygenic Risk Scores for Coronary Heart Disease: An Unfulfilled Promise of Precision Medicine.
    JAMA. 2024 Nov 16. doi: 10.1001/jama.2024.24037.
    >> Share

    October 2024
  103. ANDERER S
    Recalled Cardiovascular Devices Rarely Undergo Sufficient Testing.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20123.
    >> Share

    September 2024
  104. TU WJ, Zhao J
    Prognostic Value of Cardiovascular Biomarkers.
    JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16519.
    >> Share

  105. MANGALESH S, Nanna MG
    Prognostic Value of Cardiovascular Biomarkers.
    JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16522.
    >> Share

  106. NEUMANN JT, Twerenbold R, Ojeda F
    Prognostic Value of Cardiovascular Biomarkers-Reply.
    JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16525.
    >> Share

  107. MENG X, Li S, Dai H, Lu G, et al
    Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial.
    JAMA. 2024 Sep 12. doi: 10.1001/jama.2024.14721.
    >> Share

    August 2024
  108. ANDERER S
    New Cardiovascular Risk Calculator Could Reduce Blood Pressure Medication Prescribing.
    JAMA. 2024 Aug 16. doi: 10.1001/jama.2024.15514.
    >> Share

  109. CURFMAN G
    Chelation Therapy Following Myocardial Infarction.
    JAMA. 2024 Aug 14. doi: 10.1001/jama.2024.13549.
    >> Share

  110. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
    JAMA. 2024 Aug 14:e2411463. doi: 10.1001/jama.2024.11463.
    >> Share

    July 2024
  111. KHAN SS, Lloyd-Jones DM
    Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a Clinician to Do?
    JAMA. 2024 Jul 29. doi: 10.1001/jama.2024.13887.
    >> Share

  112. GRANT JK, Ndumele CE, Martin SS
    The Evolving Landscape of Cardiovascular Risk Assessment.
    JAMA. 2024 Jul 29. doi: 10.1001/jama.2024.13247.
    >> Share

  113. DIAO JA, Shi I, Murthy VL, Buckley TA, et al
    Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.
    JAMA. 2024 Jul 29:e2412537. doi: 10.1001/jama.2024.12537.
    >> Share

  114. GERMAN CA, Davis AM, Polonsky TS
    Management of Patients With Chronic Coronary Disease.
    JAMA. 2024 Jul 24. doi: 10.1001/jama.2024.9813.
    >> Share

  115. YEH RW, Kirtane AJ
    Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon-Reply.
    JAMA. 2024;332:169-170.
    >> Share

  116. KRATKA A, Redberg RF
    Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon.
    JAMA. 2024;332:169.
    >> Share

  117. NICHOLLS SJ, Lam CSP, Nelson AJ
    Cardiovascular Clinical Trials in the Asia-Pacific Region.
    JAMA. 2024 Jul 1. doi: 10.1001/jama.2024.6313.
    >> Share

    June 2024
  118. ANDERER S
    New Research Could Help Explain Anger's Link to Heart Attacks and Strokes.
    JAMA. 2024;331:2065-2066.
    >> Share

  119. LARKIN H
    New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions.
    JAMA. 2024 Jun 21. doi: 10.1001/jama.2024.8590.
    >> Share

    May 2024
  120. HARRIS E
    beta-Blockers After Heart Attacks Might Not Lower Deaths for Some.
    JAMA. 2024;331:1698.
    >> Share

  121. NEUMANN JT, Twerenbold R, Weimann J, Ballantyne CM, et al
    Prognostic Value of Cardiovascular Biomarkers in the Population.
    JAMA. 2024 May 13:e245596. doi: 10.1001/jama.2024.5596.
    >> Share

  122. GAZIANO TA, Gaziano JM
    Can Cardiovascular Risk Assessment Be Improved in the 21st Century?
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.7644.
    >> Share

  123. SELVARAJ S, Claggett B, Shah SH, Mentz RJ, et al
    Cardiovascular Burden of the V142I Transthyretin Variant.
    JAMA. 2024 May 12:e244467. doi: 10.1001/jama.2024.4467.
    >> Share

  124. AGGARWAL R, Ostrominski JW, Vaduganathan M
    Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020.
    JAMA. 2024 May 8:e246892. doi: 10.1001/jama.2024.6892.
    >> Share

    April 2024
  125. MCCARTHY CP, Wasfy JH, Januzzi JL Jr
    Is Myocardial Infarction Overdiagnosed?
    JAMA. 2024 Apr 24. doi: 10.1001/jama.2024.5235.
    >> Share

  126. HARRIS E
    Study Examines Intermittent Fasting and Cardiovascular Mortality.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158.
    >> Share

  127. WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al
    Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819.
    >> Share

    March 2024
  128. HARRIS E
    Plastic in Arteries Tied With Higher Risk of Cardiovascular Problems.
    JAMA. 2024 Mar 29. doi: 10.1001/jama.2024.3707.
    >> Share

  129. YEH RW, Shlofmitz R, Moses J, Bachinsky W, et al
    Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
    JAMA. 2024;331:1015-1024.
    >> Share

  130. KUNDU A, Moliterno DJ
    Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.
    JAMA. 2024;331:1011-1012.
    >> Share

  131. HARRIS E
    Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2091.
    >> Share

  132. XU J
    Sintilimab and Cardiovascular Toxicity-Reply.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0676.
    >> Share

  133. PENG L, Yang D, Weng C
    Sintilimab and Cardiovascular Toxicity.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0673.
    >> Share

  134. CHEN G, Shang M, Yang Y
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction-Reply.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0617.
    >> Share

  135. ZAKIEV V, Gvozdeva A, Skotnikov A
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0620.
    >> Share

  136. ASHAM H, Entezari-Maleki T
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0623.
    >> Share

  137. HARRIS E
    Blood Test Predicted Risk of Future Heart Attacks.
    JAMA. 2024;331:908.
    >> Share

  138. ANDERER S
    Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075.
    >> Share

  139. KO D, Pascual-Leone A, Shah SJ
    Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991.
    >> Share

  140. HARRIS E
    High Niacin Levels May Raise Cardiovascular Disease Risk.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1566.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016